COVID-19 vaccine: Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune
Zee News
"Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here," said Dr Sanjay Lalwani.
New Delhi: Phase 2/3 trials of Covovax COVID-19 vaccine in children between ages 7 and 11 began in Pune`s Bharati Vidyapeeth Medical College and Hospital on Wednesday.
"Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here," said Dr Sanjay Lalwani, the Medical Director of the hospital.
"For the children who wish to enroll their parents are counselled in local vernacular language and the audiovisual consulting process is documented. Once the parents give their consent, then the volunteer is subjected to an RT PCR test and an antibody test. Although, this does not stop them from being a part of the trial," he added.
